FAS and neoplasm: This new pipeline for treatment may not only act on the transcriptional and non-transcriptional anti-tumor activities, but can also be beneficial for the induction of anti-tumor inflammatory responses, Fas-mediated apoptosis and tumor-sensitivity to IFNγ.